Advertisement

Topics

Latest "Polytechnic Institute of New York University" News Stories

13:45 EDT 17th July 2018 | BioPortfolio

Here are the most relevant search results for "Polytechnic Institute of New York University" found in our extensive news archives from over 250 global news sources.

More Information about Polytechnic Institute of New York University on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Polytechnic Institute of New York University for you to read. Along with our medical data and news we also list Polytechnic Institute of New York University Clinical Trials, which are updated daily. BioPortfolio also has a large database of Polytechnic Institute of New York University Companies for you to search.

Showing "Polytechnic Institute York University" News Articles 1–25 of 18,000+

Tuesday 17th July 2018

First Wave Brings on Ken Rutt as Strategic Consultant

  Expertise Supports Development of the CLARITY-IA™ Respirator July 17, 2018 – Batavia, New York – Medical Conservation Device, a subsidiary of First Wave Technologies, Inc. (“First Wave” and “company”), announces that the company has engaged the consulting services of Ken Rutt, a senior level mechanical engineer and project engineer with o...


Beverly Hills Cosmetic Dentist Dr. Matt Nejad Featured On Los Angeles Radio Talk Show Behind Closed Doors

Cosmetic Dentist Dr. Matt Nejad, D.D.S. of Beverly Hills was recently featured in a segment of Behind Closed Doors, a popular Los Angeles Radio Talk Show. In a discussion about shame and its impact on sex, relationships and achievements, Dr. Nejad shares his perspective on how lack of self-worth is at the core of one’s inability to smile with confidence. LOS ANGELES (PRWEB) July 17, 2018 Dr. Ma...

Jericho Project and B&B Urban Open Walton House, First Supportive Housing Residence Under Mayor Bill de Blasio's NYC 15/15 Supportive Housing Plan

The $35.6-million dollar, 10-story building built by Jericho Project and B&B Urban in the Bronx features 89 apartments for formerly homeless and low-income veterans and young adults, many of whom identify as LGBTQ NEW YORK (PRWEB) July 17, 2018 Jericho Project, a leading nonprofit ending homelessness at its roots in New York City and B&B Urban, a long-time developer of affordable and supp...


FDA Grants Fast Track Designation to Tonix Pharmaceuticals’ Investigational Treatment for Agitation in Alzheimer’s Disease

NEW YORK, July 16, 2018 (GLOBE NEWSWIRE) — Tonix Pharmaceuticals Holding Corp. (Nasdaq:TNXP) (Tonix), today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to its investigational new drug, TNX-102 SL, for the treatment of agitation in Alzheimer’s disease. The same drug, TNX-102 SL, or Tonmya®*, for the treatment of …

Riverain Technologies Advances Clinical A.I. Through Use of Synthetic Training Data

ClearRead CT is an FDA-Cleared, Patent-Protected, Deep Learning Radiology Solution ClearRead CT™ is the only FDA-cleared (September 2016) radiology application developed using synthetic data for training a deep learning solution. The concurrent read device aids clinicians in the de

Humanetics Awarded Patent for Oral Drug to Protect Warfighters and First Responders from Radiation Exposure

Patent protects the use of Humanetics’ lead drug candidate, BIO 300, to prevent Acute Radiation Syndrome (ARS) Minneapolis-based Humanetics Corporation (Humanetics) has been awarded a United States patent for its lead drug candidate, BIO 300. The drug is being developed as a prophylactic treatment to protect warfighters and first responders at risk o...

FDA Approves Xtandi for the Treatment of Men with Non-Metastatic Castration-Resistant Prostate Cancer

TOKYO & NEW YORK–(BUSINESS WIRE)–Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., “Astellas”) and Pfizer Inc. (NYSE: PFE) today announced the U.S. Food and Drug Administration (FDA) approved a supplemental New Drug Application (sNDA) for XTANDI® (enzalutamide), following FDA Priority Review designation, based on results from the Phase 3 PROSPER trial...

Physicians’ Education Resource® Presents the 17th Annual International Congress on the Future of Breast Cancer® East

The program will discuss recent advances in the field of breast cancer, along with patient impact Physicians’ Education Resource® (PER®), the leading resource for oncology and hematology continuing medical education (CME), will the host the 17th Annual International Congress on the Future of Breast Cancer® East on July 27-28 at the InterContinenta...

Dane Street Welcomes New IME Medical Director

Dane Street, a leading URAC-accredited provider of Independent Medical Examination and Peer Review services to the Auto, Disability, Group Health and Workers’ Compensation markets, is pleased to welcome Dr. Elizabeth Bonson to the team. Dr. Bonson has accepted the position of National Medical Director, IME Services, where she will provide medical oversig...

Vizient Announces Product Categories for Quarter 3 National Group Buys Program

Siemens Healthineers is the Quarter 3 Featured Supplier Vizient, Inc., today announced the product categories and supplier savings opportunities available as part of its Quarter 3 National Group Buys Program available July 1 through September 30, 2018. The

HMP's 8th Annual Amputation Prevention Symposium Expected to Draw 800 Clinicians to Chicago to Join the CLI Revolution

Multidisciplinary gathering will provide practical education on the treatment and prevention of critical limb ischemia (CLI) MALVERN, Pa. (PRWEB) July 17, 2018 HMP, a leading healthcare events and education company, today announced the 8th Annual Amputation Prevention Symposium (AMP) will take place August 8-11, 2018 in Chicago. Led by Jihad A. Mustapha, MD, FACC, FSCAI, a pioneer in the field of...

Simpson Place Assisted Living Celebrates Skilled Nursing & Rehabilitation Expansion with Ribbon Cutting and Open House July 17, 2018

The senior care facility invites the public to attend DALLAS (PRWEB) July 17, 2018 Simpson Place Assisted Living announces a ribbon cutting and open house in celebration of the new licensed 50-bed skilled nursing and rehabilitation expansion to the assisted living and senior community in Dallas, Texas. Partnered with the Dallas Housing Authority, the new addition will provide affordable, high qua...

HemaCare Expands Development of Cellular Therapy Services by Bolstering Scientific Team with Two Strategic New Hires

Industry mavens strengthen HemaCare’s expertise in cell therapy and bioprocessing HemaCare Corporation (OTCBB: HEMA), a global leader in the customization of human-derived biological products and services for biomedical research and cell therapy, today announced two new hires in senior leadership positions. Dr. Dominic Clarke joins the company...

Catalent Experts to Discuss Oral Peptide Delivery and Advanced Modelling to Optimize Formulation at Upcoming Controlled Release Society Conference

Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced that its scientific and formulation experts will be attending and contributing to the educational agenda at the upcoming Controlled Release Society (CRS) Annual Meeting and Exposition, to be held at the New York Hilton...

K Health Launches Free Primary Care App with Providers in New York

K is the first primary care app powered by true AI and the experience of thousands of doctors and hundreds of millions of physician notes, lab results, treatments and prescriptions K Health today announced the launch of K, a free, first-of-its-kind primary care app along with a new provider network available in New York. K is the first app to us...

The US Oncology Network Promotes Leader in Value-Based Care Dr. Marcus Neubauer to Chief Medical Officer

Medical oncologist is appointed to spearhead The Network’s significant medical programs and collaborative, integrated approach to cancer care The US Oncology Network (The Network) announced the appointment of Marcus Neubauer, M.D., as its chief medical officer, building on its mission of delivering a comprehensive approach to cancer care. Mich...

White Oak Healthcare Finance Provides $20 Million for Celerity Partners’ Acquisition of Total Care Rx

White Oak Healthcare Finance, LLC (“White Oak”) today announced it acted as sole lender and administrative agent on the funding of a $20.65 million senior credit facility to finance the acquisition of Total Care Rx, Inc. (“Total Care”) by Celerity Partners. The company provides specialty, transplant, and long term care pharmacy services to over 4,0...

Large international study finds new risk genes for hay fever

In a large international study involving almost 900,000 participants, researchers from the University of Copenhagen and COPSAC have found new risk genes for hay fever. It is the largest genetic study so far on this type of allergy, which affects millions of people around the world.

Washington University’s new ALS therapy in clinical trial stage

Washington University School of Medicine’s investigational therapy for an inherited form of amyotrophic lateral sclerosis (ALS), which it had tested...Read More... The post Washington University’s new ALS therapy in clinical trial stage appeared first on Pharmaceutical Technology.

Dr. Karen Cox Named President of Chamberlain University

Dr. Susan Groenwald becomes President Emeritus Adtalem Global Education (NYSE: ATGE) today announced Dr. Karen Cox, PhD, RN, FACHE, FAAN, as the new President of Chamberlain University, and she will begin her leadership on August 27, 2018. Dr. Cox is a highly accomplished nursing and healthcare leader, who most recently served as Executive Vice Preside...

NextFlex Awards $12 Million to 7 Projects Fueling Flexible Hybird Electronics Innovations in Healthcare, Avionics and Infrastructure Monitoring

Projects include disposable health monitors that adhere to the skin, epidermal sensors for robotic knees, and conditional monitors for industry and infrastructure NextFlex®, America’s Flexible Hybrid Electronics (FHE) Manufacturing Institute, today announced $12 million (including $7M in cost-share contribution from participants) in funding for seve...

Blade Therapeutics Announces Initiation of Phase 1 Study of Lead Calpain Inhibitor BLD-2660 for Fibrosis

Blade Therapeutics, a biopharmaceutical company advancing novel anti-fibrotic therapies, today announced the initiation of a Phase 1 clinical trial for its lead compound, BLD-2660. The first-in-human Phase 1, placebo controlled, dose escalation trial is evaluating the safety and pharmacokinetics (PK) profile of orally administered BLD-2660, a sele...

Transcriptic Expands Executive Team to Support Continued Growth

Christopher Krueger joins as Chief Financial Officer and Kevin Sturdevant joins as Vice President, Business Operations Transcriptic, developer of the first robotic cloud laboratory platform, announced today the appointments of Christopher Krueger as Chief Financial Officer and Kevin Sturdevant as Vice President, Business Operations. This press re...

Journal of Diagnostic Microbiology and Infectious Disease Publishes New Clinical Study Data on Karius Test

Study Confirms Liquid Biopsy for Infectious Diseases Accurately Detects Invasive Fungal Infections Karius, a life sciences company transforming infectious disease diagnostics with genomics and data through the innovative use of next-generation sequencing to analyze microbial cell-free DNA, announced today the positive results of a clin

Phoenix Health Systems Selected for Multi-Year IT Outsourcing Partnership by Southwest Mississippi Regional Medical Center

Rural Mississippi hospital taps top-rated health IT services provider for software and hardware infrastructure support Phoenix Health Systems, the leading independent provider of hospital IT outsourcing and consulting services, today announced that Southwest Mississippi Regional Medical Center has signed a long-term contract for IT department...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks